Callan Family Office’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$450K Sell
862
-198
-19% -$101K 0.01% 805
2025
Q4
$483K Buy
1,060
+223
+27% +$97K 0.01% 793
2025
Q3
$305K Sell
837
-188
-18% -$61.9K 0.01% 702
2025
Q2
$302K Buy
+1,025
New +$228K 0.01% 773

Other funds holding FN

Callan Family Office's FN Position: Q1 2026 in Review

Callan Family Office reduced its Fabrinet (FN) stake by 19% in Q1 2026, selling an estimated $101K and leaving 862 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #805.

Callan Family Office first reported a position in FN in Q2 2025 and has held it in 4 quarters since. The position peaked at $483K in Q4 2025. 661 funds tracked by Wall St. Rank hold FN as of Q1 2026.

  • Callan Family Office held 862 shares of Fabrinet worth $450K as of Q1 2026.
  • Callan Family Office sold 198 Fabrinet shares in Q1 2026, an estimated $101K.
  • Fabrinet made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #805 holding.
  • Callan Family Office first reported a position in Fabrinet in Q2 2025 and has held it in 4 quarters since.
  • Callan Family Office's Fabrinet position peaked at $483K in Q4 2025.
  • 661 funds tracked by Wall St. Rank held Fabrinet as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.